Primary malignant melanoma of the vagina

Obstetrics and Gynecology

Volumn 116, Issue 6, 2010, Pages 1358-1365

  Frumovitz, Michael ^a   Etchepareborda, Mariano ^a   Sun, Charlotte C ^b   Soliman, Pamela T ^b   Eifel, Patricia J ^b   Levenback, Charles F ^b   Ramirez, Pedro T ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CALCULATION; CANCER RECURRENCE; CAUCASIAN; CLINICAL ARTICLE; CLINICAL FEATURE; EXCISION; FEMALE; FOLLOW UP; HUMAN; LIVER; LUNG; MEDICAL RECORD REVIEW; MELANOMA; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIS EXENTERATION; PREDICTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RECURRENCE RISK; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR VOLUME; VAGINA BLEEDING; VAGINA TUMOR; VAGINAL MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE; VAGINAL NEOPLASMS; YOUNG ADULT;

EID: 78650136990     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181fb8045     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
2. Creasman WT, Phillips JL, Menck HR. The National Cancer Data Base report on cancer of the vagina. Cancer 1998;83: 1033-40.
3. Hu DN, Yu GP, McCormick SA. Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas. Melanoma Res 2010;20:153-8.
4. Tjalma WA, Monaghan JM, de Barros Lopes A, Naik R, Nordin A. Primary vaginal melanoma and long-term survivors. Eur J Gynaecol Oncol 2001;22:20-2.
5. Signorelli M, Lissoni AA, Garbi A, Perego P, Mangioni C. Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: a case report and literature review. Gynecol Oncol 2005;97:700-3.
6. Irvin WP Jr, Bliss SA, Rice LW, Taylor PT Jr, Andersen WA. Malignant melanoma of the vagina and locoregional control: radical surgery revisited. Gynecol Oncol 1998;71:476-80.
7. Reid GC, Schmidt RW, Roberts JA, Hopkins MP, Barrett RJ, Morley GW. Primary melanoma of the vagina: a clinicopath-ologic analysis. Obstet Gynecol 1989;74:190-9.
8. McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. Cancer 2005;103:1000-7.
9. Shah CA, Goff BA, Lowe K, Peters WA 3rd, Li CI. Factors affecting risk of mortality in women with vaginal cancer. Obstet Gynecol 2009;113:1038-45.
10. Ragnarsson-Olding B, Johansson H, Rutqvist LE, Ringborg U. Malignant melanoma of the vulva and vagina: trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960-1984. Cancer 1993;71: 1893-7.
11. Buchanan DJ, Schlaerth J, Kurosaki T. Primary vaginal melanoma: thirteen-year disease-free survival after wide local excision and review of recent literature. Am J Obstet Gynecol 1998;178:1177-84.
12. Testori A, Rutkowski P, Marsden J, Bastholt L, Chiarion-Sileni V, Hauschild A, et al. Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol 2009;20 suppl 6:vi22-9.
13. Geisler JP, Look KY, Moore DA, Sutton GP. Pelvic exentera-tion for malignant melanomas of the vagina or urethra with over 3 mm of invasion. Gynecol Oncol 1995;59:338-41.
14. Temam S, Mamelle G, Marandas P, Wibault P, Avril MF, Janot F, et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer 2005;103:313-9.
15. Vongtama R, Safa A, Gallardo D, Calcaterra T, Juillard G. Efficacy of radiation therapy in the local control of desmoplas-tic malignant melanoma. Head Neck 2003;25:423-8.
16. Newlin HE, Morris CG, Amdur RJ, Mendenhall WM. Neuro-tropic melanoma of the head and neck with clinical perineural invasion. Am J Clin Oncol 2005;28:399-402.
17. Konstadoulakis MM, Ricaniadis N, Walsh D, Karakousis CP. Malignant melanoma of the anorectal region. J Surg Oncol 1995;58:118-20.
18. Ross M, Pezzi C, Pezzi T, Meurer D, Hickey R, Balch C. Patterns of failure in anorectal melanoma: a guide to surgical therapy. Arch Surg 1990;125:313-6.
19. Luna-Perez P, Rodriguez DF, Macouzet JG, Labastida S. Anorectal malignant melanoma. Surg Oncol 1996;5:165-8.
20. Roumen RM. Anorectal melanoma in The Netherlands: a report of 63 patients. Eur J Surg Oncol 1996;22:598-601.
21. Ballo MT, Gershenwald JE, Zagars GK, Lee JE, Mansfield PF, Strom EA, et al. Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma. J Clin Oncol 2002;20: 4555-8.
22. Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marin-cola FM, Topalian SL, et al. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b. J Clin Oncol 1999;17:968-75.
23. Sabel MS, Sondak VK. Point: interferon-alpha for adjuvant therapy for melanoma patients. J Natl Compr Canc Netw 2004;2:61-8.
24. Frumovitz M, Gayed IW, Jhingran A, Euscher ED, Coleman RL, Ramirez PT, et al. Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol 2008;108:478-81.
25. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307-17.